Here is, what I believe is the final paper on this clinical study I participated in:

(Open Access)

Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma Exchange

We conducted a randomized, placebo-controlled trial to assess the safety and biological age (BA) effects of various therapeutic plasma exchange (TPE) regimens in healthy adults over 50. Participants received bi-weekly TPE with or without intravenous immunoglobulin (IVIG), monthly TPE, or placebo. Randomization was based on entry date, and treatments were blinded to maintain objectivity. Primary objectives were to assess long-term TPE safety and changes in biological clocks. Secondary goals included identifying optimal regimens. Exploratory analyses profiled baseline clinical features and longitudinal changes across the epigenome, proteome, metabolome, glycome, immune cytokines, iAge, and immune cell composition. We demonstrate in 42 individuals randomized to various treatment arms or placebo that long-term TPE was found to be safe, with only two adverse events requiring discontinuation and one related to IVIG. TPE significantly improved biological age markers, with 15 epigenetic clocks showing rejuvenation compared to placebo (FDR < 0.05). Biweekly TPE combined with intravenous immunoglobulin (TPE-IVIG) proved most effective, inducing coordinated cellular and molecular responses, reversing age-related immune decline, and modulating proteins linked to chronic inflammation. Integrative analysis identified baseline biomarkers predictive of positive outcomes, suggesting TPE-IVIG is particularly beneficial for individuals with poorer initial health status. This is the first multi-omics study to examine various TPE modalities to slow epigenetic biologic clocks, which demonstrate biological age rejuvenation and the molecular features associated with this rejuvenation.

https://onlinelibrary.wiley.com/doi/10.1111/acel.70103

and here are some excerpts from The NY Times article on the study:

Cars need oil changes to keep their engines running smoothly. Some anti-aging influencers, along with a handful of scientists, believe exchanging the plasma in your blood can do a similar thing for humans to help slow biological aging. The procedure is currently offered for thousands of dollars a session at many longevity clinics.

In a car, “you change the oil every 3,000 miles because it clears out debris," said Dr. Eric Verdin, the president and chief executive of the Buck Institute for Research on Aging. Your blood, he said, can also accumulate potentially damaging particles that can be flushed out.

One of the first trials examining plasma exchange for anti-aging in humans, published Tuesday in the journal Aging Cell, offers early evidence that it may be able to slow the biological breakdown that comes with age, even in otherwise healthy people. The small study of 42 participants, with an average age of 65, found that those who got plasma exchange therapy over the course of a few months had lower concentrations in their blood of the biological compounds that accumulate with age, compared with a control group. The trial was sponsored by Circulate Health, a plasma exchange startup, and coauthored by Dr. Verdin, a company co-founder and head of the scientific advisory board.

In the Circulate Health trial, one group of subjects received an albumin infusion every few weeks or so; another group got the same infusion plus an antibody to fight infections; and a control group got only saline. Researchers used dozens of biological age tests to measure subjects’ blood several times during the full three-to-six-month regimen. They estimated that the albumin and antibody group decreased their biological age by about 2.6 years, while those on the albumin regimen saw a roughly one-year reduction. People who received only saline generally saw their biological age increase over the course of the trial.

While the Circulate Health study is “intriguing,” and suggests that plasma exchange appears to affect subjects’ blood composition even after the procedure, it doesn’t necessarily mean that it will help people live longer or healthier, said Dr. Jeffrey Winters, the chair of transfusion medicine at the Mayo Clinic. He said the trial was too small to prove anti-aging benefits; it also didn’t follow subjects for more than a few months, so it’s not clear how long the effects of plasma exchange last.

In the study, the authors hypothesized that treatments could get less effective over time as the body adjusts to the infusions. (The subjects typically didn’t show much difference in biological age after the third measurement, compared with the control, suggesting that the impact of the therapy could level off.)

https://www.nytimes.com/2025/05/28/well/plasma-exchange-longevity.html

2 Likes

Related:

and apparently they have renamed the company to Circulate Health, and here is the website:

https://www.circulate.health

2 Likes

Before anyone gets too excited, I’ll just link my post from earlier

Tl;Dr - Benefits were noted at time point 2, but not at the end of the study (time point 3). In other words, no benefit at the end of the study.

1 Like

Interestingly, the article author noted this, though incorrectly. The implication of this sentence is that there was a benefit and it leveled off, when in fact there was no benefit. I suspect this study will be paraded far and wide as proof that TPE is effective, and many people will be duped into trying it.

1 Like
1 Like

Just a short summary of my experience with this plasmapheresis clinical trial. I received 6 plasmapheresis sessions over 3+ months (perhaps about 4 months, due to xmas scheduling difficulties). I had stopped rapamycin about a month prior to joining the study (because they said no rapamycin users). As a result I was off rapamycin for over 6 months total, as there was talk of another meeting/followup after the end of the treatment series to see how long benefits might have lasted, but they didn’t do that for me.

I did not feel or notice any improvements, functionally or in any other dimension. The measures that they did (grip strength, balance, sit walk timing test, etc.) showed no real changes during the months of testing, and test administrator said I was 1st or second best on most measures in the group. I’m a reasonably healthy person, exercise 3 to 6 hours a week, and have for most of my life. Heavier than I want to be by about 10 or 15 lbs but really just want to convert more fat to muscle. Levine Phenotypic age about 12 years younger than chronological age. None of this seemed to have changed much.

And actually, I have to say generally I felt better when I was on rapamycin, than during or after the TPE sessions.

I spoke with Matt Kaeberlein at the last Longevity Summit at the Buck Institute, about my experience with TPE and he suggested that the rapamycin may have confounded my results… going off rapamycin prior to TPE sessions could have resulted in changes that would have masked or negated any benefits from the TPE program, we just don’t know. So he didn’t think we could interpret things one way or another from this N = 1.

Broadly speaking, from looking at the final results and listening to Dobri Kiprov on the study, it seems that the less healthy (and perhaps older) you are, the more likely you are to benefit from TPE.

They did not share the individual test results, blood measures and proteomics testing results with the participants - so I don’t know the details. I did one comprehensive blood test just prior to the program (they wanted this as part of the entry into the program), and they did blood testing throughout the program from the blood draws they did during the clinical study (but I never saw results). I did my own followup blood tests some months after the final TPE test, and no significant changes were seen in my measures. I was busy so it was not done as quickly afterwards that I should have done if I really wanted to see the results.

So, overall, I saw no significant measurable benefit from the 6 TPE sessions I participated in. They unblinded me after the last session, but I really believed I was in the “control” group given my apparent lack of results. But, they confirmed that I was actually in the treatment arm. For me at least, it is not something I’d do on my own $, at least for another 15 years or more. Perhaps at that point it might provide more benefit for me, and I may need it more.

3 Likes

Just stumbled upon this writeup in the NYT on the study results:

Can This Trendy Anti-Aging Treatment Really Help You Live Longer?

A small new study offers insight into plasma exchange therapy.

Cars need oil changes to keep their engines running smoothly. Some anti-aging influencers, along with a handful of scientists, believe exchanging the plasma in your blood can do a similar thing for humans to help slow biological aging. The procedure is currently offered for thousands of dollars a session at many longevity clinics.

In a car, “you change the oil every 3,000 miles because it clears out debris," said Dr. Eric Verdin, the president and chief executive of the Buck Institute for Research on Aging. Your blood, he said, can also accumulate potentially damaging particles that can be flushed out.

One of the first trials examining plasma exchange for anti-aging in humans, published Tuesday in the journal Aging Cell, offers early evidence that it may be able to slow the biological breakdown that comes with age, even in otherwise healthy people. The small study of 42 participants, with an average age of 65, found that those who got plasma exchange therapy over the course of a few months had lower concentrations in their blood of the biological compounds that accumulate with age, compared with a control group. The trial was sponsored by Circulate Health, a plasma exchange startup, and coauthored by Dr. Verdin, a company co-founder and head of the scientific advisory board.

Read the full story: Can This Trendy Anti-Aging Treatment Really Help You Live Longer? (NYTimes)